HOME >> BIOLOGY >> NEWS
Humus/Mineral interaction

University Park, Pa. --- A group of Penn State-led researchers has shown that, for some fossil fuel-based pollutants, increasing the humus content of the soil increases, rather than decreases, the likelihood that the contaminant will move to ground water.

Dr. Jon Chorover, assistant professor of environmental soil chemistry, says, "The general belief is that, as you increase the organic matter in soil, you increase the retention of contaminants. We found that that is not always the case. It depends on the nature of the compound."

Chorover and his colleagues at Penn State's Environmental Resources Research Institute and Ohio State University looked at quinoline, a nitrogen heterocyclic compound (NHC), that has been little studied to date. Quinoline belongs to the broad group of environmental contaminants, termed ionizable PACs (polycyclic aromatic compounds), often found in sites polluted by fossil fuels, solvents, greases, creosote and coal tar.

They found that if a soil is low in organic matter, quinoline is more likely to become strongly bound to the soil and less likely to move to ground water. However, in its strongly bound state, the pollutant is also less likely to be broken down by microrganisms.

The researchers detail their results in the just released current issue of the Soil Science Society of America Journal in a paper, "Quinoline Sorption on Kaolinite-Humic Acid Complexes."

Chorover's co-authors are Mary Kay Amistadi, research support associate in Penn State's Department of Agronomy; Dr. William D. Burgos, Penn State assistant professor of civil and environmental engineering; and Dr. Patrick G. Hatcher, professor of environmental chemistry, Ohio State University.

The study also shows that mineral interactions with humus were key to whether quinoline was retained in soil. When humic substances coated the mineral phase, quinoline was less likely to adhere. However, when the min
'"/>

Contact: Barbara Hale
bah@psu.edu
814-865-9481
Penn State
27-Sep-1999


Page: 1 2

Related biology news :

1. New technique helps scientists reveal interactions between genes and drugs
2. Rutgers chemist uses NMR to elucidate protein-DNA interaction
3. Findings suggest need for new view of p53 cancer proteins interaction with DNA
4. A pregnant pause for unexpected interactions
5. Butterflies & the hormonal basis of interactions between life histories & morphology
6. Seeing the forest for the trees: The future of environmental policy lies in interaction
7. Gene interactions control circadian clock in plants, study finds
8. Ability to smell food regulated by enzymes interaction with RNA interference pathway
9. Close interaction seen between blood vessel development and fat tissue formation
10. Unzipping double helix to study protein-DNA interaction
11. Invariant properties in coevolutionary networks of plant-animal interactions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Humus Mineral interaction

(Date:4/17/2014)... hundred births, Down syndrome - or trisomy 21 - ... It results from a chromosomal abnormality where cells of ... (1% of the human genome). A study conducted by ... Genetic Medicine and Development at the University of Geneva ... shed light on how the extra chromosome 21 upsets ...
(Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
(Date:4/17/2014)... channels are implicated in many serious conditions such as ... potential target for drug therapies. Unfortunately, there is still ... Cambridge research provides fresh and unexpected insight into the ... components - β-subunit molecules - which are responsible for ... published in the most recent edition of the ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: